Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Laeknabladid|January 25, 2024
[Insulin Resistance and Abnormalities in Blood Values of Icelandic Children Receiving Obesity Treatment]Anna Run Arnfridardottir, Sigrun Thorsteinsdottir, Anna Sigridur Olafsdottir, et al.
Haematologica|December 4, 2019
Fractures and survival in multiple myeloma: results from a population-based studySigrun Thorsteinsdottir, Gauti Gislason, Thor Aspelund, et al.
Blood Cancer Journal|April 8, 2026
Dietary intake and the risk of monoclonal gammopathy of undetermined significance: results from the population-based iStopMM screening studyStyrmir Hallsson, Ingibjorg Gunnarsdottir, Marianna Thordardottir, et al.
Journal of Internal Medicine|February 3, 2022
The first wave of COVID-19 and concurrent social restrictions were not associated with a negative impact on mental health and psychiatric well-beingThorvardur Jon Love, Inga Wessman, Gauti Kjartan Gislason, et al.
Blood Advances|January 4, 2018
Bone disease in monoclonal gammopathy of undetermined significance: results from a screened population-based studySigrun Thorsteinsdottir, Sigrun H Lund, Ebba K Lindqvist, et al.
Ejhaem|April 18, 2024
Nationwide implementation of lenalidomide maintenance in multiple myeloma: A retrospective, real-world studyMads Harsløf, Iman Chanchiri, Trine Silkjær, et al.
Haematologica|September 4, 2025
Use of upfront autologous stem cell transplantation in myeloma patients aged >65 years: a population-based study by the Nordic Myeloma Study GroupKari Lenita Falck Moore, Samundur Rognvaldsson, Agoston G Szabo, et al.
Blood Cancer Journal|December 18, 2024
The significance of free light-chain ratio in light-chain monoclonal gammopathy of undetermined significance: a flow cytometry sub-study of the iStopMM screening studyJón Þórir Óskarsson, Sæmundur Rögnvaldsson, Sigrun Thorsteinsdottir, et al.
British Journal of Haematology|December 25, 2024
Monoclonal gammopathy of undetermined significance and the risk of thrombotic events: Results from iStopMM, a prospective population-based screening studySæmundur Rögnvaldsson, Alessandro Gasparini, Sigrun Thorsteinsdottir, et al.
Blood Cancer Journal|September 13, 2022
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM studyThorir Einarsson Long, Olafur Skuli Indridason, Runolfur Palsson, et al.
Pageof 3